Toptal identifies critical vulnerabilities to protect digital assets for biotechnology firm.
A biotechnology company needed to secure its Django application ahead of a product launch. Toptal conducted a comprehensive penetration test to uncover vulnerabilities and reduce risks to sensitive data.
Client
A US-based biotechnology company developing RNA-based research and discovery solutions for drug development.
Employees
Revenue
Industry
Healthcare & Life SciencesDelivered Services
Get a free consultation now
Schedule a CallChallenge
Security gaps in the application created exposure to potential data breaches and financial loss. The organization required a rapid, thorough assessment to identify and address critical risks before launch.
Solution
Comprehensive Penetration Testing
Toptal performed a full penetration test to identify exploitable vulnerabilities and assess real-world attack scenarios.
Targeted Security Analysis
Toptal uncovered critical issues, including insecure configurations, delivering detailed recommendations to strengthen the app.
Outcome
Critical Risks Mitigated
Toptal addressed key vulnerabilities, preventing potential financial losses estimated in the millions if data were leaked publicly.
Stronger Security Posture
Detailed reporting and stakeholder training improved long-term security practices and reduced future risk exposure.
Get a free consultation now
Schedule a Call